Literature DB >> 9886899

Left ventricular systolic function in primary aldosteronism and hypertension.

G P Rossi1, A Sacchetto, E Pavan, R Scognamiglio, M Pietra, A C Pessina.   

Abstract

OBJECTIVE: This study was designed to investigate whether the excess aldosterone found in primary aldosteronism (PA) influences left-ventricular systolic function (LVSF), through a positive inotropic effect
METHODS: M-mode and two-dimensional echocardiography and transmitral Doppler flow velocity measurements were performed in 82 patients: 44 with confirmed PA (23 male; 21 female; aged 51.8+/-13 years) and 38 essential hypertension patients (16 male; 22 female; aged 48.5+/-12 years) matched for demography and blood pressure (BP) values. We measured left-ventricular (LV) midwall fractional shortening (MwFSho) and LV circumferential end-systolic stress (cESS, calculated according to Reichek's equation) and analysed the relationship between MwFSho and cESS.
RESULTS: These are given as the mean +/- standard deviation. PA patients had significantly higher cardiac index (CI) (3.55+/-0.94 l/m2 vs 2.98+/-0.58, P < 0.005) and lower E wave/A wave time-velocity integral ratio (0.93+/-0.27 vs 1.26+/-0.41, P < 0.001) than EH, whereas mean BP (126+/-12 mmHg vs 128+/-12), MwFSho (17.1+/-2.4% vs 16.3+/-1.9), cESS (118+/-19 Kdynes/cm2 vs 121+/-18) and the relationship between LV MwFSho and LV cESS did not differ between groups.
CONCLUSION: These findings confirm that PA patients exhibit: (1) a modest increase of CI; (2) an LV diastolic filling mainly occurring with the atrial kick. However, they do not lend support to the contention that the excess of plasma aldosterone seen in PA is associated with enhanced LV inotropism under resting conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886899     DOI: 10.1097/00004872-199816121-00032

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  The Role of Aldosterone in Obesity-Related Hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Am J Hypertens       Date:  2016-02-28       Impact factor: 2.689

Review 2.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 3.  MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

Review 4.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

5.  Central mineralocorticoid receptors and cardiovascular disease.

Authors:  Elise P Gomez Sanchez
Journal:  Neuroendocrinology       Date:  2009-07-07       Impact factor: 4.914

Review 6.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

Review 7.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

Review 8.  Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity.

Authors:  Manav Nayyar; Guido Lastra; Camila Manrique Acevedo
Journal:  Curr Hypertens Rep       Date:  2018-08-14       Impact factor: 5.369

Review 9.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

Review 10.  Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.

Authors:  Sumaiya Ahmed; Gregory L Hundemer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-26       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.